Man Group PLC Selecta Biosciences Inc Transaction History

Man Group PLC

  • $35.6 Billion
  • Q4 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$1.15 - $1.89 $43,700 - $71,820
38,000 Added 24.33%
194,183 $269,000
Q4 2022

Feb 14, 2023
BUY
$0.96 - $1.6 $19,226 - $32,044
20,028 Added 14.71%
156,183 $176,000
Q3 2022

Nov 14, 2022
BUY
$1.33 - $2.6 $118,299 - $231,262
88,947 Added 188.42%
136,155 $223,000
Q2 2022

Aug 15, 2022
BUY
$0.67 - $1.4 $31,629 - $66,091
47,208 New
47,208 $61,000
Q1 2022

May 16, 2022
SELL
$1.23 - $3.31 $221,384 - $595,756
-179,987 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.89 - $4.43 $1,722 - $2,640
596 Added 0.33%
179,987 $587,000
Q3 2021

Nov 15, 2021
BUY
$3.36 - $4.62 $80,485 - $110,667
23,954 Added 15.41%
179,391 $746,000
Q2 2021

Aug 16, 2021
SELL
$2.82 - $5.01 $159,922 - $284,117
-56,710 Reduced 26.73%
155,437 $650,000
Q1 2021

May 17, 2021
SELL
$2.92 - $5.07 $214,173 - $371,869
-73,347 Reduced 25.69%
212,147 $960,000
Q4 2020

Feb 16, 2021
BUY
$1.64 - $3.42 $82,127 - $171,266
50,078 Added 21.27%
285,494 $865,000
Q3 2020

Nov 16, 2020
BUY
$2.18 - $2.84 $200,719 - $261,487
92,073 Added 64.23%
235,416 $584,000
Q2 2020

Aug 14, 2020
BUY
$1.83 - $4.06 $191,637 - $425,163
104,720 Added 271.13%
143,343 $407,000
Q1 2020

May 15, 2020
SELL
$1.5 - $4.52 $1.23 Million - $3.72 Million
-822,522 Reduced 95.51%
38,623 $93,000
Q4 2019

Feb 18, 2020
SELL
$1.32 - $2.47 $3.66 Million - $6.85 Million
-2,772,531 Reduced 76.3%
861,145 $2.05 Million
Q3 2019

Nov 14, 2019
SELL
$1.6 - $2.08 $36,633 - $47,623
-22,896 Reduced 0.63%
3,633,676 $6.36 Million
Q2 2019

Aug 14, 2019
BUY
$1.79 - $3.05 $11,635 - $19,825
6,500 Added 0.18%
3,656,572 $6.55 Million
Q1 2019

May 15, 2019
BUY
$1.47 - $3.06 $4.58 Million - $9.53 Million
3,115,614 Added 582.95%
3,650,072 $8.65 Million
Q4 2018

Feb 14, 2019
BUY
$2.66 - $15.93 $737,200 - $4.41 Million
277,143 Added 107.71%
534,458 $1.42 Million
Q3 2018

Nov 14, 2018
BUY
$12.07 - $16.0 $1.81 Million - $2.39 Million
149,685 Added 139.07%
257,315 $4 Million
Q2 2018

Aug 14, 2018
BUY
$9.36 - $13.25 $1.01 Million - $1.43 Million
107,630 New
107,630 $1.43 Million

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email